(Total Views: 422)
Posted On: 09/13/2019 1:14:15 PM
Post# of 149263
It was a deal between Protein Design Labs (now AbbVie) and Progenics that CYDY inherited when purchasing PRO 140. Maybe PDL made the molecule for Progenics?
As far as these payments, I think they are on CYDY....whether they pay for it with these milestone payments or other funding they have available at the time due. I understood NP that $50M is the low-end cost to launch a product......so I think this is BP expense (not sure if that is part of the $90M or not) and they will pay all launch costs. Maybe someone more knowledgeable of these type of deals can clarify if $90M milestone payments include the launch costs or not?
Quote:
the payment to the company that sold Leronlimab to Cytodyn, would that be part of the upfront 50mil for launch
As far as these payments, I think they are on CYDY....whether they pay for it with these milestone payments or other funding they have available at the time due. I understood NP that $50M is the low-end cost to launch a product......so I think this is BP expense (not sure if that is part of the $90M or not) and they will pay all launch costs. Maybe someone more knowledgeable of these type of deals can clarify if $90M milestone payments include the launch costs or not?
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
